Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J George

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The American Journal of Cardiology|December 31, 1997
High-speed rotational atherectomy of human coronary stenoses: acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registryD L Brown, C J George, A R Steenkiste, et al.
The American Journal of Cardiology|December 31, 1997
Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registryJ P Carrozza, R A Schatz, C J George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast CancerAnand Shah, Erik Bloomquist, Shenghui Tang, et al.
The American Journal of Cardiology|December 31, 1997
Directional coronary atherectomy (DCA): a report from the New Approaches to Coronary Intervention (NACI) registryR Waksman, J J Popma, E D Kennard, et al.
The American Journal of Cardiology|December 31, 1997
Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experienceD R Holmes, S Mehta, C J George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR Angelo de Claro, Karen M McGinn, Nicole Verdun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast CancerMelanie Royce, Christy L Osgood, Anup K Amatya, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The American Journal of Cardiology|December 31, 1997
High-speed rotational atherectomy of human coronary stenoses: acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registryD L Brown, C J George, A R Steenkiste, et al.
The American Journal of Cardiology|December 31, 1997
Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registryJ P Carrozza, R A Schatz, C J George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast CancerAnand Shah, Erik Bloomquist, Shenghui Tang, et al.
The American Journal of Cardiology|December 31, 1997
Directional coronary atherectomy (DCA): a report from the New Approaches to Coronary Intervention (NACI) registryR Waksman, J J Popma, E D Kennard, et al.
The American Journal of Cardiology|December 31, 1997
Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experienceD R Holmes, S Mehta, C J George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR Angelo de Claro, Karen M McGinn, Nicole Verdun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast CancerMelanie Royce, Christy L Osgood, Anup K Amatya, et al.
Pageof 3